FDA inspection
New York Blood Center Enterprises: FDA inspection ending Apr 3, 2026
FDA inspection 1311062 · Rye, NY
Key facts
| Inspection ID | 1311062 |
|---|---|
| Firm | New York Blood Center Enterprises |
| FEI number | 2473015 |
| Address | 601 Midland Ave |
| City | Rye |
| State | NY |
| ZIP | 10580-4000 |
| Fiscal year | 2026 |
| Inspection end date | Apr 3, 2026 |
| Project area | Blood and Blood Products |
| Product type | Biologics |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data